Breaking News

Covance Acquires Medaxial

May 20, 2014

Expands global market access offerings

Covance has acquired Medaxial, a communication consultancy that specializes in offering an integrated approach to market access strategy, health economic modeling, and data dissemination services to the pharma, biopharma and medical device industries.
 
Based in London, with offices in NY, Antwerp, and Belgium, Medaxial expands Covance’s market access services currently located in Gaithersburg, MD, Greenfield, IN, San Diego and Sydney. 
 
"Covance is a leader in the rapidly growing sector of market access and reimbursement.  Medaxial, with their proven expertise in optimizing data-driven, solution-focused communication of a medical product's value will further complement our market access offerings," said Marc Ginsky, vice president and general manager, Covance Market Access. "Proactive and effective communication of clinical and economic value is critical to help clients navigate an increasingly complex drug development and payment landscape, as they strive to provide innovative medical products to patients."
 
"Our capabilities and our commitment to client service are in line with Covance's commitment to operational and service excellence," said Paul Mcloughlin, co-founder and Director, Technology and Design, Medaxial. "This acquisition will provide clients with the benefits of a global consultancy group with local expertise."

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Tackling Drug Serialization Challenges

    Tackling Drug Serialization Challenges

    Tim Wright, editor||January 22, 2016
    Siemens and Adents together will develop a combined hardware plus software solution for pharma industry

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016